OSsIRIS Post-Market Clinical Study
Real-world safety & performance of b.Bone
Post-MarketActive
Key Facts
Indication
Real-world safety & performance of b.Bone
Phase
Post-Market
Status
Active
Company
About GreenBone Ortho
GreenBone Ortho is a private, commercial-stage medical device company pioneering a novel biomaterial for bone regeneration. Its core technology transforms the natural microstructure of rattan wood into an inorganic, biomimetic hydroxyapatite scaffold that mimics human cancellous bone. With its CE-marked product b.Bone already on the market and supported by clinical evidence, the company is targeting a significant global opportunity in the bone graft substitute market. Key investors include 3B Future Health Fund, Innogest SGR, and CDP Venture Capital, providing financial backing for its commercial expansion and R&D.
View full company profile